Sharon A. Shellard

499 total citations
14 papers, 436 citations indexed

About

Sharon A. Shellard is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sharon A. Shellard has authored 14 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Sharon A. Shellard's work include Cancer therapeutics and mechanisms (7 papers), Chemotherapy-induced organ toxicity mitigation (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Sharon A. Shellard is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Chemotherapy-induced organ toxicity mitigation (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Sharon A. Shellard collaborates with scholars based in United Kingdom, United States and Netherlands. Sharon A. Shellard's co-authors include Bridget T. Hill, Louise K. Hosking, Richard D. H. Whelan, Philip Bedford, Anne Marie J. Fichtinger-Schepman, Siobhán McClean, Hartmut Land, Laurent Deleu, Konstantinos Alevizopoulos and Bruno Amati and has published in prestigious journals such as Oncogene, International Journal of Radiation Oncology*Biology*Physics and International Journal of Cancer.

In The Last Decade

Sharon A. Shellard

14 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon A. Shellard United Kingdom 10 281 201 44 44 43 14 436
Linda Hogarth United Kingdom 14 387 1.4× 152 0.8× 48 1.1× 56 1.3× 33 0.8× 29 666
Moses Adeyanju United States 8 294 1.0× 143 0.7× 68 1.5× 57 1.3× 21 0.5× 8 471
A. Aquino Italy 14 238 0.8× 265 1.3× 28 0.6× 18 0.4× 53 1.2× 27 529
Naoto Ohi Japan 12 276 1.0× 169 0.8× 53 1.2× 23 0.5× 30 0.7× 19 519
K W Kohn United States 7 325 1.2× 234 1.2× 60 1.4× 13 0.3× 25 0.6× 9 465
Doreen K. Hom United States 10 236 0.8× 205 1.0× 26 0.6× 29 0.7× 18 0.4× 15 371
J Siracký Slovakia 11 179 0.6× 220 1.1× 46 1.0× 29 0.7× 51 1.2× 43 474
T. S. Ravikumar United States 9 182 0.6× 109 0.5× 26 0.6× 48 1.1× 74 1.7× 15 367
D. Godelaine Belgium 10 382 1.4× 133 0.7× 18 0.4× 38 0.9× 19 0.4× 14 677
M. Claire Walker United Kingdom 10 391 1.4× 229 1.1× 74 1.7× 32 0.7× 22 0.5× 12 538

Countries citing papers authored by Sharon A. Shellard

Since Specialization
Citations

This map shows the geographic impact of Sharon A. Shellard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon A. Shellard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon A. Shellard more than expected).

Fields of papers citing papers by Sharon A. Shellard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon A. Shellard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon A. Shellard. The network helps show where Sharon A. Shellard may publish in the future.

Co-authorship network of co-authors of Sharon A. Shellard

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon A. Shellard. A scholar is included among the top collaborators of Sharon A. Shellard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon A. Shellard. Sharon A. Shellard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Deleu, Laurent, Sharon A. Shellard, Konstantinos Alevizopoulos, Bruno Amati, & Hartmut Land. (2001). Recruitment of TRRAP required for oncogenic transformation by E1A. Oncogene. 20(57). 8270–8275. 70 indexed citations
2.
3.
Hosking, Louise K., Richard D. H. Whelan, Sharon A. Shellard, et al.. (1994). Multiple mechanisms of resistance in a series of human testicular teratoma cell lines selected for increasing resistance to etoposide. International Journal of Cancer. 57(2). 259–267. 11 indexed citations
4.
Hill, Bridget T., Richard D. H. Whelan, Sharon A. Shellard, Siobhán McClean, & Louise K. Hosking. (1994). Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublinesin vitro. Investigational New Drugs. 12(3). 169–182. 93 indexed citations
5.
Dempke, Wolfram C. M., Sharon A. Shellard, Louise K. Hosking, Anne Marie J. Fichtinger-Schepman, & Bridget T. Hill. (1992). Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro. Carcinogenesis. 13(7). 1209–1215. 28 indexed citations
6.
Hill, Bridget T., Sharon A. Shellard, Louise K. Hosking, et al.. (1992). Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.. PubMed. 52(11). 3110–8. 17 indexed citations
7.
Whelan, Richard D. H., et al.. (1991). A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistance. International Journal of Cancer. 47(6). 899–902. 9 indexed citations
8.
9.
Hill, Bridget T., Sharon A. Shellard, Louise K. Hosking, Anne Marie J. Fichtinger-Schepman, & Philip Bedford. (1990). Enhanced dna repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation. International Journal of Radiation Oncology*Biology*Physics. 19(1). 75–83. 47 indexed citations
10.
Hosking, Louise K., Richard D. H. Whelan, Sharon A. Shellard, Philip Bedford, & Bridget T. Hill. (1990). An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines. Biochemical Pharmacology. 40(8). 1833–1842. 88 indexed citations
11.
Hill, Bridget T., Richard D. H. Whelan, Louise K. Hosking, et al.. (1990). Differential expression of drug resistance following in vitro exposure of human tumour cell lines to fractionated X-irradiation. Cancer Treatment Reviews. 17. 21–26. 8 indexed citations
12.
Dempke, Wolfram C. M., Sharon A. Shellard, Anne Marie J. Fichtinger-Schepman, & Bridget T. Hill. (1990). A lack of significant modulation of the formation and removal of platinum-DNA adducts in logarithmically growing human ovarian tumor cell lines in vitro by aphidicolin addition. Cancer Treatment Reviews. 17. 92–93. 1 indexed citations
13.
Shellard, Sharon A., et al.. (1990). Mechanisms of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Biochemical Society Transactions. 18(4). 622–622. 1 indexed citations
14.
Bedford, Philip, Sharon A. Shellard, M. Claire Walker, et al.. (1987). Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre‐exposed in vitro to either X‐irradiation or cisplatin. International Journal of Cancer. 40(5). 681–686. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Hogarth Breakdown of academic impact, for papers by Moses Adeyanju Breakdown of academic impact, for papers by A. Aquino Breakdown of academic impact, for papers by Naoto Ohi Breakdown of academic impact, for papers by K W Kohn Breakdown of academic impact, for papers by Doreen K. Hom Breakdown of academic impact, for papers by J Siracký Breakdown of academic impact, for papers by T. S. Ravikumar Breakdown of academic impact, for papers by D. Godelaine Breakdown of academic impact, for papers by M. Claire Walker
Rankless by CCL
2026